|

Adverse Outcomes and Mortality in Liver Transplant

RECRUITINGN/ASponsored by Mayo Clinic
Actively Recruiting
PhaseN/A
SponsorMayo Clinic
Started2022-11-02
Est. completion2026-07-01
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT05477277

Summary

Prospective natural history pilot study to explore the link between muscle composition using an MRI-based Muscle Assessment Score (MAsS) and adverse outcomes in liver transplant candidates.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

1. All patients with end-stage liver disease undergoing evaluation for liver transplantation
2. Patient clinically indicated for MRI during transplant candidacy evaluation
3. Adult

Exclusion Criteria:

1\. Contra indication to MRI

Conditions5

CirrhosisEnd Stage Liver DiseaseLiver DiseaseSarcopeniaSarcopenic Obesity

Locations1 site

Mayo Clinic Arizona
Phoenix, Arizona, 85259
Elizabeth Carey, MD480-342-1094

Browse More Trials

Liver Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.